Holen Sie sich die Stockscreener-App
6.73
1.97%
0.13
Vorhandelsmarkt:
6.89
0.16
+2.38%
Immix Biopharma Inc Aktie (IMMX) Neueste Nachrichten
Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX) - Seeking Alpha
Immix Biopharma Stock Surges 70%, With A 6-Day Winning Spree - Trefis
Immix Biopharma CFO Gabriel Morris buys $5k in shares - Investing.com
Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares - Investing.com
Immix Biopharma CFO Gabriel Morris buys $5k in shares By Investing.com - Investing.com India
Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright - Investing.com Australia
Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright By Investing.com - Investing.com South Africa
Immix Biopharma closes $93.7 million public offering By Investing.com - Investing.com Canada
Immix Biopharma closes $93.7 million public offering - Investing.com
Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants - marketscreener.com
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - The Manila Times
Immix Biopharma (IMMX) closes $100M offering, nets $93.7M from biotech funds - Stock Titan
Immix Biopharma prices $100M equity raise via common stock and warrant offering - MSN
IMMX Analyst Rating Update: HC Wainwright Raises Price Target to - GuruFocus
Taking the lead: Immix Biopharma Inc (IMMX) - Setenews
Immix Biopharma — Promising NEXICART-2 data; runway extended - Smartkarma
Immix Biopharma Enters Underwriting Agreement with Morgan Stanley - TipRanks
Form 424B5 Immix Biopharma, Inc. - StreetInsider
Immix Biopharma’s Market Dynamics Amid Economic Shifts - timothysykes.com
Immix Soars On NXC-201 Data In Relapsed/Refractory AL Amyloidosis; BLA Planned For 2026 - Nasdaq
Immix Biopharma Prices $100 Million Offering - marketscreener.com
Immix Biopharma Announces Positive Phase 2 Trial Results - TipRanks
Form FWP Immix Biopharma, Inc. Filed by: Immix Biopharma, Inc. - StreetInsider
Immix Biopharma, Inc. Announces Positive Phase 2 NXC-201 Results - TradingView
Immix Biopharma prices $100 million public offering to fund AL amyloidosis drug - Investing.com Nigeria
Immix Biopharma reports 75% complete response rate for NXC-201 By Investing.com - Investing.com Nigeria
Immix Biopharma reports 75% complete response rate for NXC-201 - Investing.com
Immix Biopharma prices offering of 19.1 million shares at $5.10 per share - marketscreener.com
Immix Biopharma Prices Offering Of 19.1 Million Shares At $5.10 Per Share - TradingView
Immix Biopharma (IMMX) sets price for upsized $100M stock and pre-funded warrant offering - Stock Titan
Immix Biopharma (IMMX) reports 75% CR at ASH 2025, plans 2026 NXC-201 BLA - Stock Titan
Best Biotech Stocks Right Now • Updated Daily - Benzinga
Is Immix Biopharma Inc (IMMX) positioned for future growth? - Setenews
Immix Biopharma, Inc.'s (NASDAQ:IMMX) market cap rose US$18m last week; retail investors who hold 56% profited and so did insiders - simplywall.st
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher – What’s Next? - Defense World
What analysts say about Immix Biopharma Inc stockSector Rotation Strategies & Our Experts Decode Market Noise for You - earlytimes.in
Is Immix Biopharma Inc a good long term investmentMarket Depth Overview & Watch and Learn From Live Trades - earlytimes.in
Will Immix Biopharma Inc. stock benefit from automationJuly 2025 Catalysts & Accurate Intraday Trade Tips - BỘ NỘI VỤ
Immix Biopharma appoints Michael Grabow as chief commercial officer to drive NXC-201 launch - MSN
A significant driver of top-line growth: Immix Biopharma Inc (IMMX) - Setenews
Immix Biopharma Updates Accounting Firm Consents - MSN
Immix Biopharma files updated auditor consents for SEC registration statement - Investing.com Nigeria
Immix Biopharma Inc. (IMMX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Immix Biopharma Updates Auditor Consents for Registration Statement - TradingView
[8-K] Immix Biopharma, Inc. Reports Material Event | IMMX SEC FilingForm 8-K - Stock Titan
Is Variman Global Enterprises Limited Worth Holding Through Market ReversalDividend Cut Warnings & Low Cost Capital Trading - earlytimes.in
We Think Immix Biopharma (NASDAQ:IMMX) Needs To Drive Business Growth Carefully - Yahoo Finance
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Will Immix Biopharma Inc. stock rally after Fed decisionsQuarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
Working capital per share of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Can trapped investors hope for a rebound in Immix Biopharma Inc.July 2025 Recap & High Conviction Buy Zone Picks - newser.com
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):